A Combination Drug Treats Hepatitis C in Patients of HIV

Published By : 22 Jul 2014 |Published By : QYRESEARCH

Gilead Sciences Incorporated, Solvadi, is controversial due to its price. This drug helps to cure the condition of hepatitis C in people that have HIV, as stated by researches who believe that his drug has the potential to limit the top cause of fatality in these patients.

In the study around 223 HIV-infected patients used Solvadi in combination with ribavirin. This cleared the most common strain in U.S. of hepatitis C in around seventy-six patients over twenty-four weeks. In the study, only seven participants discontinued the treatment because of the side affects they experienced. However, there were no adverse effects on the treatment for HIV, according to a report published in the Journal of the American Medical Association.

Complications arising from hepatitis C are considered to be the leading cause for patients with HIV, was stated by the research study. In the past, around 7 million for treatment co-infected with the viruses worldwide which has limited because of older hepatitis C polices which include interferon interact badly with HIV drugs and more with fatigue, anemia, and depression is present, was said by the researchers.

During the first clinical trial, the researchers were able to demonstrate that they can cure hepatitis C with HIV co-infection with the use of interferon. The study author of the report also said that this represents a transformative step in their approach to the therapeutic area.

A doctor Raymond Chung, who works at the Massachusetts General Hospital, said that they can achieve excellent effects with the co-infection in a way where they have achieved mono-infections.